SecBot SecBot
COURT-RULING ·Filed Jun 2, 2026

MDXG

MIMEDX GROUP, INC.
BULLISH
Impact 5/10
Horizondays Processed5mo ago CourtCourt Ruling · courtlistener.com
Court ruling (appellate)
Actionable Insight ▲ Bullish

The voluntary dismissal of the appeal removes a litigation overhang for MiMedx. Traders should monitor for any related settlement terms or remaining district court proceedings, but the immediate risk of an adverse appellate ruling is eliminated.

DirectionBullish
Confidencehigh
Horizondays

How the stock moved after the report

BULLISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$3.57
T+0 close · Jun 2, 2026 · via day close
Latest settled
+23.81%
T+60 · $4.42
Vs SPY
+22.69%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 2 $3.57entry
  2. T+1 · 6mo ago +1.12%α +1.81% · $3.61
  3. T+5 · 5mo ago +3.92%α +6.89% · $3.71
  4. T+20 · 5mo ago +9.24%α +10.81% · $3.90
  5. T+60 · 3mo ago +23.81%α +22.69% · $4.42
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

The Federal Circuit dismissed the appeal in Mimedx Group, Inc. v. Surgenex, LLC by agreement of the parties, with each side bearing its own costs. This voluntary dismissal removes uncertainty from the litigation, as no adverse ruling was entered against MiMedx.

Court Ruling Details

Ruling Date
Jun 2, 2026
Court
United States Court of Appeals for the Federal Circuit
Court Level
Appellate
Case Type
other
Ruling Type
other
Outcome
SETTLEMENT: parties reached agreement
Precedent Risk
LOW

Key Facts

  • Appeal dismissed under Fed. R. App. P. 42(b) by agreement of the parties
  • Each side to bear its own costs
  • Dismissal issued as mandate on June 2, 2026
  • Original case was in the Western District of Texas

Financial Impact

No damages, costs, or financial penalties awarded; litigation risk removed

litigation_exposure

Risk Factors

  • Terms of any underlying settlement between the parties are not disclosed
  • Potential for related litigation or future disputes not covered by this dismissal

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
92% bullish (12 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 court opinion.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-3q2385wp-MDXG

Track record

10 reports on MDXG

Performance horizon

3 of 4 bullish or bearish reports moved the stock their way by T+5. Best: +26.86% at T+20 after the Oct 16, 2026 report. 3 of 4 went positive at some point.

Filters
  1. Nov 12, 20264d ago SC 13G Neutral 4/10 Entry $3.21 Now $3.18 −0.93% settles Nov 20
  2. Oct 28, 202619d ago 8-K Bearish 6/10 No price data
  3. Oct 28, 202619d ago Press Release Bearish 6/10 Entry $3.97 to $3.28 Now $3.18 +19.90% ▲ +17.38% +12.65% vs SPY
  4. Oct 28, 202619d ago Press Release Bullish 5/10 Entry $3.97 to $3.28 Now $3.18 −19.90% ▼ −17.38% −12.65% vs SPY
  5. Oct 16, 20264w ago 425 Mixed 5/10 Entry $4.43 to $3.91 Now $3.18 −28.22% ▼ −11.74% −11.83% vs SPY
  6. Oct 16, 20264w ago 8-K Bearish 6/10 Entry $4.43 to $3.91 Now $3.18 +28.22% ▲ +11.74% +11.83% vs SPY
  7. Jun 2, 202624w ago Court Ruling Bullish 5/10 Viewing Entry $3.57 to $3.71 Now $3.18 −10.92% ▲ +3.92% +6.89% vs SPY
  8. Apr 29, 202628w ago DEFA14A Neutral 3/10 Entry $3.36 to $3.66 Now $3.18 −5.36% ▲ +8.93% +7.20% vs SPY
  9. Apr 22, 202629w ago Press Release Neutral 1/10 Entry $3.31 to $3.27 Now $3.18 −3.93% ▼ −1.36% −1.41% vs SPY
  10. Apr 16, 202630w ago 8-K Bearish 7/10 Entry $3.43 to $3.35 Now $3.18 +7.29% ▲ +2.33% +3.32% vs SPY
Showing 10 of 10

US Market Status

Market Closed · Opens in 6h 13m

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
⚖ Court Ruling · courtlistener.com Report published Jun 2, 2026